Man Group’s Esperion Therapeutics ESPR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-25,692
Closed -$42.4K 1883
2024
Q3
$42.4K Buy
+25,692
New +$42.4K ﹤0.01% 1784
2024
Q2
Sell
-440,770
Closed -$1.18M 1946
2024
Q1
$1.18M Buy
440,770
+223,785
+103% +$600K ﹤0.01% 1374
2023
Q4
$649K Buy
+216,985
New +$649K ﹤0.01% 1479
2023
Q3
Sell
-117,251
Closed -$163K 1837
2023
Q2
$163K Buy
+117,251
New +$163K ﹤0.01% 1802
2023
Q1
Sell
-18,100
Closed -$113K 1923
2022
Q4
$113K Buy
+18,100
New +$113K ﹤0.01% 1885
2022
Q3
Hold
0
-$300K 2032
2022
Q2
Sell
-112,903
Closed -$524K 1686
2022
Q1
$524K Buy
+112,903
New +$524K ﹤0.01% 1546
2021
Q4
Sell
-15,756
Closed -$190K 1907
2021
Q3
$190K Buy
15,756
+1,978
+14% +$23.9K ﹤0.01% 1745
2021
Q2
$291K Sell
13,778
-14,248
-51% -$301K ﹤0.01% 1678
2021
Q1
$786K Sell
28,026
-9,554
-25% -$268K ﹤0.01% 1355
2020
Q4
$977K Buy
37,580
+19,969
+113% +$519K ﹤0.01% 1418
2020
Q3
$655K Buy
17,611
+281
+2% +$10.5K ﹤0.01% 1480
2020
Q2
$889K Buy
17,330
+10,992
+173% +$564K ﹤0.01% 1306
2020
Q1
$200K Sell
6,338
-276,658
-98% -$8.73M ﹤0.01% 1459
2019
Q4
$16.9M Buy
282,996
+76,369
+37% +$4.55M 0.06% 419
2019
Q3
$7.58M Sell
206,627
-52,056
-20% -$1.91M 0.03% 682
2019
Q2
$12M Buy
258,683
+24,566
+10% +$1.14M 0.04% 542
2019
Q1
$9.4M Buy
234,117
+70,331
+43% +$2.82M 0.04% 599
2018
Q4
$7.54M Buy
163,786
+20,218
+14% +$930K 0.03% 564
2018
Q3
$6.37M Buy
143,568
+120,357
+519% +$5.34M 0.02% 849
2018
Q2
$910K Buy
+23,211
New +$910K ﹤0.01% 1618